Television News

Prof. Pablo Fernandez-Peñas discusses the important role of VECTRA® WB360 in the launch of ACEMID

Prof. Pablo Fernandez-Peñas of the University of Sydney was recently interviewed on 7News Australia as the University of Queensland and the Australian Cancer Research Foundation announced the official launch of the Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID). Prof. Fernandez-Peñas highlighted the VECTRA WB360 and explained how 15 WB360 systems will be installed as part of this initiative bringing together researchers from the University of Queensland, University of Sydney, and Monash University to study melanoma using the system’s advanced body mapping technology. Prof. Peñas is hopeful that up to 15,000 Australians across the states of Queensland, New South Wales, and Victoria will take part in future screenings using the VECTRA WB360, enabling researchers to collect images and develop advanced algorithms to aide melanoma detection.

10 News First Discusses Canfield’s VECTRA® WB360 whole-body imaging system, and ongoing melanoma research in Australia with Prof. H Peter Soyer

University of Queensland’s Prof. H Peter Soyer discusses Canfield’s VECTRA WB360 and its role in expanding Australian melanoma research with 10 New First. Researchers plan to create a database of over 100,000 clinically-accessible VECTRA WB360 patient images, enhancing melanoma screening, early diagnosis, and long-term skin surveillance. The system’s presence at multiple locations in Australia is possible as part of a AUS $10 million grant from the Australian Cancer Research Foundation, as they are using the DermaGraphix advanced body mapping technology to combat the nation’s high rate of melanoma. The VECTRA WB360 captures cross polarized and non-polarized images to create a precise 3D body map of the patient. This 3D body map provides clinicians and researchers the ability to identify changes in suspicious lesions on the surface of the skin over time.

Dr. Allan Halpern of Memorial Sloan Kettering Cancer Center discusses VECTRA® WB360 technology on CBS News

CBS News interviewed Dr. Allan Halpern, Chief of Dermatology at Memorial Sloan Kettering Cancer Center, about the VECTRA WB360’s advanced imaging technology and its role assisting doctors in detecting signs of melanoma. Dr. Halpern demonstrated how the system captures cross-polarized and non-polarized images using 92 cameras firing simultaneously, providing an accurate 3D representation of the patient’s skin. The system’s DermaGraphix bodymap software enables clinicians to track significant lesion changes automatically and mark them for follow up imaging. The VECTRA WB360 provides clinicians like Dr. Halpern a powerful tool to screen patients thoroughly, especially important now since so many have missed their normal appointments in the past year due to the pandemic. The Journal of American Academy of Dermatology reported as many as 19,600 melanomas may not have been diagnosed or treated in 2020. Dr. Halpern explained that he is leveraging technology like the WB360 to “help do a better job, to catch melanoma at the earliest possible stage while at the same time avoiding a lot of unnecessary biopsies.”

Canfield’s VECTRA® WB360 assists INOVA Melanoma and Skin Cancer Center with patient surveillance and clinical research

Canfield’s VECTRA WB360 3D whole-body imaging system has been assisting doctors and specialists at INOVA Melanoma and Skin Cancer Center as they screen patients for skin cancer and conduct melanoma research. Since its installation in February 2019, the WB360 has provided body mapping technology and advanced 3D research tools to INOVA’S team of board certified dermatologists, oncologists, surgeons and pathologists. The VECTRA WB360’s non-polarized and cross-polarized images assist Dr. Suraj Venna, Director of the INOVA Melanoma and Skin Cancer Center, and fellow team members to identify skin changes quickly using the system’s automatic AI-driven lesion change technology. The VECTRA WB360 enables INOVA’s clinicians, physicians, and researchers to provide an unparalleled level of care for their patients. 

Canfield’s VECTRA® WB360 featured on Seven Network’s Sunrise morning show considered a “major breakthrough” in melanoma surveillance

Australia’s Seven Network Sunrise morning show featured the VECTRA WB360® whole-body 3D imaging system as a “technological breakthrough” for melanoma surveillance. Hosts David Koch and Natalie Barr discuss the whole-body imaging system with Associate Prof. Victoria Mar of Monash University in Melbourne, where she explains how the system’s advanced body mapping technology assists doctors in making more accurate melanoma diagnoses. Prof. Mar also mentions the infrastructure grant from the Australian Cancer Research Foundation, where 15 VECTRA WB360 systems will be placed in clinics across Queensland, New South Wales, and Victoria. The systems set up in these states will be part of a larger telehealth network, enabling patients in remote areas to take part in a very thorough risk assessment study. Prof. Mar explains how the approach using the VECTRA WB360 will help researchers monitor melanoma on a long-term basis and will place an emphasis on reaching remote patients so they can receive the highest level of care.

Dermatology Solutions launches world’s first VECTRA® WB360 3D whole body imaging solution in a DICOM-based teledermatology service, delivering the most advanced level of care to the broadest possible patient base

Dermatology Solutions in Central Queensland, Australia, is the first in the world to implement Canfield’s WB360 in a teledermatology service, using DICOM file sharing and communication technology. The system generates detailed, high resolution 3D images that are sent first to dermatologists for assessment and diagnosis, then made available to the patient’s GP, enabling more thorough local treatment for patients in remote areas. Clinicians in this Rockhampton office image patients with the system’s 92 high-definition cameras and, using the 3D body mapping technology, identify and track suspicious lesions and rashes.

  On NBC 6 South Florida, NewBeauty Magazine Features VISIA® as a Top Tech Product for Improving Your Skin

NBC 6 South Florida recently featured VISIA® as one of NewBeauty’s  top tech products for improving your skin. NewBeauty editor-at-large, Sarah Eggenberger, discussed VISIA’s innovative capture module and facial skin analysis software which helps detect fine lines, wrinkles, UV damage, and other underlying skin conditions. If you’re interested in fillers, VISIA’s Advanced Aging Simulation shows how you’ll look after erasing those wrinkles.  Images taken by VISIA enhance communication between the client and physician, and assists with creating the perfect treatment regimen for the client.

Professor Peter Soyer of UQ Dermatology Declares VECTRA® WB360 a “Game Changer” in Early Detection of Melanoma

On Channel 7's House of Wellness, The University of Queensland highlights the VECTRA WB360 as an advanced whole-body imaging system used to identify and track lesions. Hosts Luke Darcy and Jo Stanley discuss the WB360’s 92-camera capture system and 3D body-mapping technology’s value and importance to skin screening in Australia. 

Baptist Health Monitors High-risk Skin Cancer Patients With VECTRA® WB360 3D Imaging Technology

The Miami Cancer Institute at Baptist Health South Florida demonstrates using the VECTRA WB360 to capture whole body images of a patient’s skin to screen for the earliest signs of skin cancer. Dr. Naiara Braghiroli explains how the WB360 stands out against other total body systems with its ability to capture the entire patient’s skin surface with 92 high definition cameras. Using these photos to create a single baseline image of the whole body, the advanced 3D body mapping technology displays all the moles on the patient’s body, helping doctors quickly examine individual lesions and monitor for potential skin cancer.

IntelliStudio® and D200evo Help Prof. Petr Arenberger Provide Skin Exams Across the Czech Republic

The “Anti-Melanoma Pavillion” has been held annually in the Czech Republic for 14 years. It offers patients the opportunity for a whole body skin check without making an appointment at the hospital out-patient department. The “street mole clinic“ began again with its usual long queues of eager patients at Wenceslas Square in Prague. This year, patients were examined using the Canfield IntelliStudio® and D200evo to provide the most effective and fast skin assessment. The popular event is organized by Prof. Petr Arenberger, Director of the University Hospital Kralovske Vinohrady University Hospital in Prague, and Professor and Chairman at the Department of Dermatology. Two additional Anti-Melanoma Pavillion days will be held in the Czech cities of Brno and Ostrava.